AV078 for Epilepsy in Tuberous Sclerosis Complex
Part of Brain & nervous system, Cancer, Genetic & congenital clinical trials.
This trial tests an investigational drug called AV078 for people with Tuberous Sclerosis Complex (TSC) whose seizures have not been controlled by other medications. The goal is to see if AV078 can help reduce seizures safely.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 12 years old or older.
- You have been diagnosed with Tuberous Sclerosis Complex (TSC) – a genetic condition that can cause seizures and other symptoms.
- Your seizures have not been well controlled despite trying at least 2 different anti-seizure medications.
- You are on a stable dose of your current seizure medication that has not changed in the last 4 weeks.
- You have not taken antibiotics or certain other medications (like immune-suppressing drugs) in the last 4 weeks.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether rapamycin (compared with a placebo) can reduce seizures caused by tuberous sclerosis complex (TSC) that have not been controlled by usual medicines. If you qualify, you may be helping doctors find a safer and more effective option for seizure control.
This Phase 2 trial tests SPN-817 in adults whose seizures are still not well controlled despite trying multiple seizure medicines. It targets people with a specific type of brain finding called focal cortical dysplasia and looks at safety/tolerability and seizure outcomes over several weeks.
This Phase 2 study tests whether sirolimus (a targeted medicine) can stop or slow the start of seizures in very young babies diagnosed with tuberous sclerosis complex (TSC). If seizures are prevented early, it may also help protect early brain development.
This study tests a procedure that uses tiny electrodes to find and treat the area of the brain causing seizures in people with a specific type of epilepsy that does not get better with medication.
This trial tests a new implanted device that detects and stops seizures before they spread. It is for people with difficult-to-control focal seizures who have not had success with medicines.
This trial tests a new type of stimulation placed under the skin to help control seizures in people with epilepsy. It is for patients whose seizures are not controlled with medication and who cannot have surgery.
Hear when a new Epilepsy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.